The BioBusiness program supports the growth of companies and the commercialisation of research
outcomes for the global market.   It aims to develop world class export-oriented products and businesses.

BioBusiness Programs are designed to assist small biotechnology business to grow, expanding into
international markets and attracting new biotechnology investment in NSW.

To help bring their products to the market Biomimetics Pty Ltd has been awarded a $64,000 Australian
Government Commercialising Emerging Technologies (COMET) grant.

Mr Macfarlane said "Patients who require bone joint operations will be the big beneficiaries of this process
which produces synthetic bone material with strength approaching that of natural bone, reducing the need
for mechanical fixes, The product has the potential to allow bone graft material to be used in load-bearing
bone repair sites and the process can also be used to apply improved coatings to orthopaedic implants."

"Nanocoatings has applied for patents over these process technologies and is seeking to commercialise
several products based on them, potentially earning Australia significant export dollars," Mr Macfarlane said.

One of three winners announced in May 2006 for the Future Materials Awards 2006. The technology has won
the Future Materials Award in the Biotechnology Category. For more details check the Future materials awards
website http://www.future.org.au/award2006/award.html